Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000559689 | SCV000652972 | benign | Acroosteolysis-keloid-like lesions-premature aging syndrome; Basal ganglia calcification, idiopathic, 4; Infantile myofibromatosis; Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001550038 | SCV001770306 | likely benign | not provided | 2021-03-12 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316722 | SCV004016552 | benign | Myeloproliferative disorder, chronic, with eosinophilia | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001550038 | SCV004157351 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | PDGFRB: BP4, BP7, BS1, BS2 |
Prevention |
RCV003935506 | SCV004747349 | benign | PDGFRB-related disorder | 2019-07-02 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001724058 | SCV001808338 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001724058 | SCV001956277 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001550038 | SCV001970832 | likely benign | not provided | no assertion criteria provided | clinical testing |